a-Thrombin, a serine protease with potent procoagulant activity, has the capacity to stimulate the proliferation of fibroblasts, vascular endothelial cells and macrophages. However, for the latter cell type, esterolytically intact enzyme is not required and, in fact, the mitogenic potency of the molecule appears to reside in a limited unique region of thrombin termed the 8-loop peptide (B-LP). In an attempt to determine the mechanism by which B-LP mediates mitogenesis, B-LP sensitive 5774.1 macrophage cells were fixed in paraformaldehyde and incubated for 1 hr with lZ51 BzLP in the presence and absence of exogenous unlabeled ligand (10 'O-l0-~)(n=5).
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The data show that the 5744.1 cells possess a specific, saturable B-LP receptor that exhibits a Kd of -1.12 nM; a value that coincides with the concentration of peptide necessary to optimally elicit a mitogenic response in these cells. Native a-thrombin, inactivated DIPthrombin and unlabeled B-LP displace bound lZ5-labeled B-LP from 5774 cells at equimolar concentrations suggesting that all the 3 peptides interact with a common receptor site on macrophages.
Scatchard analysis indicates that -4000 such receptors are present per cell. We suggest that ligand activation of these receptors is responsible for triggering the biological response associated with thrombin-stimulated macrophages, and therefore, is likely pivotal in promoting the accumulation of these cells during the processes of inflammation and wound healing. Table) .
IOSS OF HEPATITlS
Evidence of HBsAb (n=37) or exposure to hepatitis vaccine (n=10) was found in 87% of HTLV-111 positive patients at some time during their care i n our clinic. However, 17% demonstrated subsequent antibody loss and/or did not respond to hepatitis vaccine. This unusual HBsAb response was restricted to patients < 17 years of age (63% of all patients). This result contrastFd to only a 2% loss of HBsAb or vaccine non-response in the HTLV-111 negative patients who had previously been positive for HBsAb (n=24) or were given the hepatitis vaccine (n=16). This result suggests that loss or a1 teration of hepatitis B immunity in children occurs as a result of HTLV-I11 infection or exposure. The hematologic manifestations of 100 pediatric patients with AIDSIARC were reviewed. Acute or chronic anemia was present in 94% of all patients. Two patients had autoimmune hemolytic anemia and 1 patient had an aplastic anemia. A positive Coombs test was detected in 40% of all patients. Leukopenia and neutropenia occurred in 50% and 40% of patients respectively. Antineutrophil antibodies were detected in 2 patients. Ten of 13 children developed neutropenia on Bactrim. Forty percent of all children were lymphopenic. Monocytosis and eosinophilia occurred in 66% and 40% of patients respectively. Thrombocytopenia was seen in 33% and of these 25% developed a persistent thrombocytopenia. Platelet antibodies were detected in 10 of 11 patients. Pancytopenia occurred in 20% of children with opportunistic infection (0.1.).
Acquired Von Willebrands disease and autoantibodies to Factors X, XI and XI1 were seen in 2 individuals. Peripheral smears revealed ovalocytes, microcytosis, hypochromia and atypical lymphocytes. Bone marrow examination showed hypercellularity, myeloid hyperplasia and increased plasma cells and lymphocytes. Decreased erythropoeisis, dy~m~elopoeisis, dyserythropoeisis and megaloblastic changes were occasionally seen. Bone marrow cultures were positive for mycobacterium avium intra cellulare (4), candida (2) and CMV (1) in a total of 7 patients. We transferred new genetic information into human cell lines and hematopoietic stem cells using retrovirus vectors. These vectors, containing the dominant selectable gene (neo) for resistance to the antibiotic G418, were introduced into amphotropic helper viruses to achieve a high frequency transduction into human cells. Human cell lines or freshly obtained human marrow cells were co-cultivated with irradiated vector producing cells, and cultured in clonogenic assays with and without G418. Survival curves of non-transfected cells with increasing concentrations of G418 resulted in a dose-dependent inhibition of colony growth with a final dose of 500 to 800 !.Ig/ml. Transfected promyelocytic leukemia (HL-60), erythroleukemia (OCI-M2) and different lymphoid cell lines with N2 and SV(X) vectors, revealed G418 resistant colonies in frequencies ranging from 3.2 to 44%. Similar frequencies were found with human marrow cells. Transfection with either N2 or NEOp Vectors produced G418 resistant hematopoietic progenitor colonies of the erythroid (BFU-E) granulocyte-macrophage (CFU-GM), and mixed (GFU-GEMM) lineages in frequencies ranging from 8 to 40% after 14 days in culture. We conclude that selected retrovirus vectors can be successfully used to insert new genetic inforpation into pluripotent and committed human hematopoietic progenitor cells.
GENETIC MANIPULATION OF HUMAN HEMATOPOIETIC

E KARYOTYPIC, I A .
A 9 yo black male with acute leukemia showed a unique chromosome abnormality and unusual phenotypic and genotypic features. He presented with fever, lethargy, weight loss, and cervical adenitis without organomegaly or enlarged thymus. The Hgb was 4.6 gm/dl, platelets 50,00O/dl, and WBC 25,00O/dl, 96% blasts of moderate size with scanty-cytoplasm and indistinct nucleoli. Some were larger with more cytoplasm and had nucleoli. The marrow blasts were larger, had large nuclei, prominent nucleoli, a moderate amount of bascphilic cytoplasm and no auer rods. They were 42% Sudan black and 20% peroxidase positive, FAB-41. Immunophenotyping showed T-cell markers (Leu 1.9)-88%, B-cel 1 markers (Leu 12)-448, myeloid markers (My 9)-5%. Dr (1a)-O%, and
TdT-29%. The cells were negative for surface and cytoplasmic immunoglobulin (Ig). Karyotyping showed 46,XY,t(l; 10) (p32; p13), in all cells analyzed. Southern blots showed Ig heavy chain and T-cell receptor 6-chain gene rearrangement. In summary, the patient had acute leukemia with L1 or L2-M1 peripheral blasts. The marrow cells were FAB L2-M1 and histochemically were MI. Imnunophenotyping showed features of B-cells (leu12) and T-cells (leul,leu9) . The Ig heavy chain and T-receptor 6-chain genes were rearranged. All cells had a new translocation, t(l:10) (p32:p13). Gvilfoile, T E K 2 X $ t o~r C e n t e r , Cincinnati.
Vaso-occlusive sickle cell crises have been described with onset during sleep. Nineteen sleep studies were performed on 14 children with sickle cell disease to evaluate oxygen saturotion during sleep.
The patients, age 4 to 17 years, were selected based upon the number and frequency of crises, and history of nocturnal crises. Total sleep time (TST) and percent TST as rapid eye movement (REM) were comparable to normals for age. Changes in respiratory dynamics (apnea ond hypopnea) and oxygen saturation were monitored during sleep. Four individuals experienced I to 2 episodes of apnea per night. Six children in 8 studies demonstrated I to 48 hypopneic events. Oxygen desoturation was defined as a > 4% drop from boseline or 5 90% actual saturation. The durotiox of desaturation was quantitated in 14 of 19 studies. Desoturation associated with apnea or hypopneo was appreciated in only four studies. The total accurnulotive duration of desaturation was I to 9 minutes per study.
Oxygen desoturation not associated with changes in respiratory dynamics occurred in all but one patient. The overage duration of desaturation was 20 minutes (range 3 to 100 min.) These data reveal marked oxygen desaturation during sleep in a subset of patients with sickle cell disease, and suggest a relationship between desaturation and increased frequency of vaso-occlusive crises.
